What Analysts Said After Bristol-Myers' Quick Lung Drug Approval By: Benzinga via Benzinga March 05, 2015 at 09:35 AM EST Bristol-Myers Squibb Co (NYSE: BMY) shot higher on Wednesday, gaining more than 6 percent after its lung cancer drug received ... Read More >> Related Stocks: Bristol-Myers Squibb UBS Group Ag ADR